A series of pharmacokinetic studies of ceftaroline fosamil in select populations: Normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis-Reference-Cited by-同舟云学术

A series of pharmacokinetic studies of ceftaroline fosamil in select populations: Normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis

Published:2014-01-22 Issue:7 Volume:54 Page:742-752
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:J Clin Pharmacol

Author:

Riccobene Todd¹,Jakate Abhijeet¹,Rank Doug²

Affiliation:

1. Forest Research Institute, Inc.; Jersey City NJ USA

2. Cerexa, Inc. (a wholly-owned subsidiary of Forest Laboratories, Inc., New York, New York); Oakland CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States;Ge;Antimicrob. Agents Chemother,2008

2. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study;Jones;J Antimicrob Chemother,2011

3. Antimicrobial activities of ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus;Sader;Antimicrob Agents Chemother,2008

4. Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains;Sader;Antimicrob Agents Chemother,2005

5. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity;Biek;J Antimicrob Chemother,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics in older people: an overview of prescribing practice;Journal of Prescribing Practice;2024-09-02

2. Ceftaroline Fosamil as a Potential Treatment for Central Nervous System Infections in Children;Infectious Diseases in Clinical Practice;2024-06-14

3. Respiratory Infections in the Aging Lung: Implications for Diagnosis, Therapy, and Prevention;aging and disease;2024

4. New Antimicrobials for Gram-Positive Sustained Infections: A Comprehensive Guide for Clinicians;Pharmaceuticals;2023-09-15

5. Pharmacokinetics of Antibacterial Agents in the Elderly: The Body of Evidence;Biomedicines;2023-06-04